12961631 · Active · incorporated 6 years ago · London
Biotech Biotech & Life Sciences Drug Discovery Series B+
Kesmalea Therapeutics is a biopharmaceutical company developing novel therapeutics based on protein degradation for new medicines.
Kesmalea Therapeutics Limited is a private limited company registered at Companies House under number 12961631, incorporated on 20 October 2020, with a registered office in London. Its current status on the register is active. Its filed nature of business is research and experimental development on biotechnology (SIC 72110). Sonde has indexed 65 filings for this company, including 4 funding rounds. Its most recent round closed in October 2026, raising £21.9m.
| Round | Closed | Raised | Price per share |
|---|---|---|---|
| Round 4 | Oct 2026 | £21.9m | £0.6055 |
| Round 3 | Sep 2024 | £10m | £1.00 |
| Round 2 | Sep 2023 | £10m | £1.00 |
| Round 1 | Sep 2022 | £5m | £1.00 |
Showing the 12 most recent of 65 filings.
See the complete cap table with every shareholder, founder tags, dilution across 15 share allotments, round-by-round fundraising history, and the full filing timeline — parsed from official Companies House documents.
Create a free account Sign inFree accounts open 3 companies in full detail — no card required.